NCT04886999View on ClinicalTrials.gov

Study in Adult Patients With Moderate to Severe Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Asthma
Interventions
BEHAVIORAL

Exploratory study on patient's perception of Asthma symptoms

To assess the perception of symptoms and the psychopharmacological aspects in patients with moderate to severe asthma comparing two inhalers of CHF1535 100/6 µg pMDI

Trial Locations (10)

Unknown

Chiesi 38011, Bari

Chiesi 38009, Battipaglia

Chiesi 38006, Cagliari

Chiesi 38010, Catanzaro

Chiesi 38003, Genova

Chiesi 38001, Milan

Chiesi 38005, Napoli

Chiesi 38004, Palermo

Chiesi 38002, Roma

Chiesi 38007, Sassari

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY